Structures of ApoB100 show LDL receptor contact points ...
NASA scientists launched the Parker Solar Probe on what they call “a mission to touch the sun.” Since then, the spacecraft ...
GEMMA Biotherapeutics, the start-up that gene therapy pioneer Jim Wilson founded earlier this year, has raised $34 million in ...
Researchers have tested strategies to combine riboswitches—RNA motifs that change conformation in response to binding another molecule—with these aptamers to create biosensors that fluoresce only when ...
Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly ...
New York and Copenhagen–based start-up HERVolution Therapeutics has raised $11.7 million in series A financing. The company is developing therapeutics that target human endogenous retroviruses ...
“2025 will see breakthroughs in the precision chemistry of chiral materials and the physics arising from structural chirality. Driven by organic materials in earlier years, significant leaps in ...
BASF has opened a catalyst development center in Ludwigshafen, Germany, after a “high double-digit million euro million” investment. BASF will conduct pilot-scale synthesis of catalysts and ...
Nearly all black plastics get sent to the landfill or get incinerated because their pigment makes them difficult to sort in plastics recycling plants. As a result, the recycling industry pays ...
This electron microscope image shows a closeup view of the nirmuli flower, Hygrophila auriculata. Nirmuli plants are known for their rich iron content, earning the herb a place in ayurvedic ...
Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly ...
Number of fluorinated drugs that may be subject to future restrictions. This summer the anti-HIV medication lenacapavir showed a 100% success rate in Phase 3 clinical trials. But under the ...